According to DelveInsight's' estimates, Gout Market in 7MM is expected to show positive growth, during the study period (2019-2032)

"The increase in Gout Market size is a direct consequence of an increase in R& D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM"

The potential drugs recently launched in the Gout Market or expected to get launched in the market during the study period 2019-2032

The Gout Market Insights report from DelveInsight provides a thorough understanding of the Gout Market size by treatment, epidemiology, emerging therapies, Gout market share of the various therapies, and the current and forecasted Gout Market size from 2019 to 2032 divided into the 7MM (the USA, EU5 (Germany, France, Italy, Spain, and the UK), and Japan) regions.

Key Takeaways from Gout Market Research Report
• According to DelveInsight, the Gout Market in 7MM is expected to witness a major change in the study period 2019-2032
• The US Population reported physician-diagnosed prevalent gout. The male to female ratio was 3:1.
• In the UK, based on the Clinical Practice Research Data Link, the prevalence of gout was 2.49% (95% CI, 2.48-2.51%) in 2012.
• Gout is common in Europe, with studies in France, Germany, Greece, Italy, the Netherlands, Spain and the UK findings a gout prevalence ranging from 1% to 4% for the period 2003-2014, which has been confirmed in subsequent studies from other European countries.
• Gout Market Companies include Horizon Therapeutics, Menarini International Operations, Dyve Biosciences, Selecta Biosciences, and many others
• Gout Market Therapies include Krystexxa, Adenuric, DYV-700, ImmTOR + Pegadricase(SEL-212), and many others

Discover which therapies are expected to grab major Gout Market Report @ https://www.delveinsight.com/sample-request/gout-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Gout Overview
Gout is a common form of inflammatory arthritis. It's due to a crystal called uric acid. Gout causes pain and swelling in one or more joints. It typically affects the big toe. But it's also found in other joints, including the knee, ankle, foot, hand, wrist and elbow. It is more common in men than in women. Gout usually develops in middle age.

Gout Epidemiology Insights
When there is too much uric acid in the body, uric acid crystals (monosodium urate) can build up in joints, fluids, and tissue within the body. Hyperuricemia, however does not always cause gout, and hyperuricemia without gout symptoms does not need to be treated.

Gout Epidemiology Segmentation in the 7MM
• Total Gout Prevalent Cases
• Gout Gender-specific Prevalent Cases
• Gout Age-specific Prevalent Cases
• Gout Diagnosed and Treatable Cases

Gout Treatment Market
The treatment of gout is divided into three phases: treatment of the acute attack, uric acid-lowering therapy, and prevention of acute flares. Treatment of acute attacks: For the treatment of acute attacks NSAIDs (nonsteroidal anti-inflammatory drugs), corticosteroids and colchicine are used. Health care providers may prescribe a short-treatment course of anakinra (Kineret), a biologic drug, though this medication is not FDA-approved for the treatment of gout. Though the US FDA does not approve this rheumatoid arthritis drug for gout treatment, it can quickly relieve gout symptoms for some patients.

Gout Market Insights
Recent advances in technology, together with a better understanding of the pathophysiology of gout, have led to better non-invasive tools facilitating the diagnosis and management of gout. The accelerating use of ultrasound and dual-energy computed tomography is contributing to improvements in gout diagnosis, study, and management.

Major Gout Treatment Options
• NSAIDs (Indomethacin, naproxen, etc.)
• Corticosteroids (Prednisone, methylprednisolone, and triamcinolone)
• Colchicine
• Drugs to reduce excess uric acid (allopurinol, febuxostat, probenecid, lesinurad, etc.)

Download the report to understand which factors are driving the Gout Treatment or Therapies @ https://www.delveinsight.com/sample-request/gout-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Gout Emerging Therapy Assessment
Key players, such as Dyve Biosciences, Selecta Biosciences, LG Chem, Horizon Therapeutics, etc., are involved in developing therapies for the treatment and prevention of Gout. Several potential therapies for Gout are under investigation. These include newer agents, including DYV-700 (Dyve Biosciences), ImmTOR + Pegadricase (Selecta Biosciences), and LC350189 (LG Chem), SAP-001 (Shanton Pharma), which are undergoing evaluation in Gout.

Scope of the Gout Market Research Report
• Coverage- 7MM
• Study Period- 2019-2032
• Forecast Period- 2022-2032
• Gout Market Companies include Horizon Therapeutics, Menarini International Operations, Dyve Biosciences, Selecta Biosciences, and many others
• Gout Market Therapies include Krystexxa, Adenuric, DYV-700, ImmTOR + Pegadricase(SEL-212), and many others
• Gout Market Drivers and Barriers
• KOL Views
• Gout Market Access and Reimbursement

Table of content
1. Key Insights
2. Executive Summary of Gout
3. Competitive Intelligence Analysis for Gout
4. Gout: Market Overview at a Glance
5. Gout: Disease Background and Overview
6. Patient Journey
7. Gout Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Gout Unmet Needs
10. Key Endpoints of Gout Treatment
11. Gout Marketed Products
12. Gout Emerging Therapies
13. Gout: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Gout Market Outlook
16. Access and Reimbursement Overview of Gout
17. KOL Views
18. Gout Market Drivers
19. Gout Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Got Queries? Reach out for more information of the report's key players @ https://www.delveinsight.com/report-store/gout-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.